|

XMT-1660 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Mersana Therapeutics1

Indications

  • Primary Peritoneal Cavity Cancer1
  • Adenoid Cystic Carcinoma1
  • Fallopian Tube Cancer1
  • Triple Negative Breast Cancer1
  • Endometrial Cancer1

Phoenix, Arizona1 trial

A Study of XMT-1660 in Participants With Solid Tumors

Mayo Clinic Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.